2020
DOI: 10.1007/s00408-020-00389-4
|View full text |Cite
|
Sign up to set email alerts
|

Utility of Bronchoalveolar Lavage and Transbronchial Biopsy in Patients with Interstitial Lung Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 33 publications
1
7
0
Order By: Relevance
“…Variables that were significantly associated with change in diagnosis (p-value <0.2) were included in multivariable model to test independent associations. All p-values less than 0.05 were considered significant [ 5 ]. Statistical analyses were performed using MedCalc Statistical Software version 19.2.6 (MedCalc Software bv Ostend, Belgium; https://www.medcalc.org ; 2020).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Variables that were significantly associated with change in diagnosis (p-value <0.2) were included in multivariable model to test independent associations. All p-values less than 0.05 were considered significant [ 5 ]. Statistical analyses were performed using MedCalc Statistical Software version 19.2.6 (MedCalc Software bv Ostend, Belgium; https://www.medcalc.org ; 2020).…”
Section: Methodsmentioning
confidence: 99%
“…Bronchoalveolar lavage and transbronchial biopsy can increase diagnostic confidence in the diagnosis of hypersensitivity pneumonitis (HP) [1][2][3]. Bronchoscopy is particularly useful in patients with a high-resolution computed tomography (HRCT) that is not consistent with UIP, in those with identified antigen exposure, and in those who do not meet criteria for connective tissue disease related ILD [4,5]. While sensitivity of transbronchial biopsy (TBBx) is much lower than surgical lung biopsy (SLB) due to smaller sample size, the complication rate of TBBx is less than that of SLB [4,[6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Bronchoalveolar lavage (BAL) is unlikely to change a clinical and serological diagnosis of CTD-ILD ( 37 ). While BAL fluid cytology has been described in various subtypes of ILD, findings are non-specific, and therefore the role of BAL in ASyS assessment is limited.…”
Section: Assessment Of Lung Diseasementioning
confidence: 99%
“…We suggest evaluating for subclinical myositis by checking aldolase and creatine kinase (CK) at baseline and periodically every 6–12 months, particularly in patients with positive anti-synthetase antibodies, MDA-5 antibody, or anti-PM-Scl antibody. Elevated acute phase markers (erythrocyte sedimentation rate [ESR] or C-reactive protein [CRP]) have been shown to be prognostically relevant in various RD-ILDs [ 39 41 ] and in IPAF [ 25 , 26 ].…”
Section: Evaluation and Treatmentmentioning
confidence: 99%